Orion
Kari Jussi Aho has extensive board experience across multiple organizations, currently serving as a Board Member for Teknos and Orion Corporation since June 2023 and May 2020, respectively. Aho is actively involved in E, holding positions as a Yrittäjävaltuuskunnan jäsen and its puheenjohtaja, as well as the Vice Chairman of the Board for Aho Group since June 2021. Other roles include Board Member for Talous ja nuoret TAT and Aava Terveyspalvelut Oy. Aho's previous experience includes significant contributions to Rukakeskus Ltd / Pyhätunturi Ltd as Chairman of the Board and Managing Director. Aho holds a KTM in Marketing and an MBA from Helsingin kauppakorkeakoulu.
This person is not in any teams
This person is not in any offices
Orion
1 followers
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, Finnish heritage rare diseases and respiratory diseases for which Orion develops inhaled Easyhaler® pulmonary drugs.